BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2046708)

  • 1. Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells.
    Busch MP; Eble BE; Khayam-Bashi H; Heilbron D; Murphy EL; Kwok S; Sninsky J; Perkins HA; Vyas GN
    N Engl J Med; 1991 Jul; 325(1):1-5. PubMed ID: 2046708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody.
    Ward JW; Holmberg SD; Allen JR; Cohn DL; Critchley SE; Kleinman SH; Lenes BA; Ravenholt O; Davis JR; Quinn MG
    N Engl J Med; 1988 Feb; 318(8):473-8. PubMed ID: 3422337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated human immunodeficiency virus type 1 from screened antibody-negative blood donors.
    Roberts CR; Longfield JN; Platte RC; Zielmanski KP; Wages J; Fowler A
    Arch Pathol Lab Med; 1994 Dec; 118(12):1188-92. PubMed ID: 7979912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of testing for human immunodeficiency virus.
    Bylund DJ; Ziegner UH; Hooper DG
    Clin Lab Med; 1992 Jun; 12(2):305-33. PubMed ID: 1611822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of human immunodeficiency virus type 1 p24 antigen in U.S. blood donors--an assessment of the efficacy of testing in donor screening. The HIV-Antigen Study Group.
    Alter HJ; Epstein JS; Swenson SG; VanRaden MJ; Ward JW; Kaslow RA; Menitove JE; Klein HG; Sandler SG; Sayers MH
    N Engl J Med; 1990 Nov; 323(19):1312-7. PubMed ID: 2120589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor.
    Simonds RJ; Holmberg SD; Hurwitz RL; Coleman TR; Bottenfield S; Conley LJ; Kohlenberg SH; Castro KG; Dahan BA; Schable CA
    N Engl J Med; 1992 Mar; 326(11):726-32. PubMed ID: 1738377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.
    Stramer SL; Glynn SA; Kleinman SH; Strong DM; Caglioti S; Wright DJ; Dodd RY; Busch MP;
    N Engl J Med; 2004 Aug; 351(8):760-8. PubMed ID: 15317889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G; Yan Y; Yang B; Shao C; Wang F; Li Q; Seed CR
    Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody-negative.
    Cumming PD; Wallace EL; Schorr JB; Dodd RY
    N Engl J Med; 1989 Oct; 321(14):941-6. PubMed ID: 2779616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.
    Lackritz EM; Satten GA; Aberle-Grasse J; Dodd RY; Raimondi VP; Janssen RS; Lewis WF; Notari EP; Petersen LR
    N Engl J Med; 1995 Dec; 333(26):1721-5. PubMed ID: 7491134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology.
    Scuracchio PS; Poli MC; Lemos MM; Oliveira Filho AG; Salles NA; Chamone DA; Magri M; Cavalcante NJ; Collela R
    Transfus Med; 2007 Jun; 17(3):200-4. PubMed ID: 17561863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.
    Gibellini D; Vitone F; Schiavone P; Ponti C; La Placa M; Re MC
    J Clin Virol; 2004 Apr; 29(4):282-9. PubMed ID: 15018857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. New York City Collaborative Study of Maternal HIV Transmission and Montefiore Medical Center HIV Perinatal Transmission Study Group.
    Rogers MF; Ou CY; Rayfield M; Thomas PA; Schoenbaum EE; Abrams E; Krasinski K; Selwyn PA; Moore J; Kaul A
    N Engl J Med; 1989 Jun; 320(25):1649-54. PubMed ID: 2725615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery.
    Cohen ND; Muñoz A; Reitz BA; Ness PK; Frazier OH; Yawn DH; Lee H; Blattner W; Donahue JG; Nelson KE
    N Engl J Med; 1989 May; 320(18):1172-6. PubMed ID: 2710190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of human T-cell leukemia virus types I and II in Switzerland.
    Böni J; Bisset LR; Burckhardt JJ; Joller-Jemelka HI; Bürgisser P; Perrin L; Gorgievski M; Erb P; Fierz W; Piffaretti JC; Schüpbach J;
    J Med Virol; 2004 Feb; 72(2):328-37. PubMed ID: 14695678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.